COLLPLANT BIOTECHNOLOGIES LT

CLGNNASDAQ

🏆 #3815 by market capEarnings Aug 18US Equity

$455.59▼ $28.16 (−6.18%)

Simulated price

1h—

24h▼ 6.2%

7d—

14d—

30d—

1y—

🏦Market Cap

$6M

Small Cap

📈Revenue Growth (YoY)

-84.3%

Declining

📊Gross Margin

-147.6%

Thin

💵FCF Margin

—

⚖️P/S Ratio

15.8x

Expensive

Otter Score

43

Weak

Earnings

Q4 · 2025Reported 2025-12-31

Earnings Per Share

Actual

-0.26

Expected

-0.19

miss

−34.20%

Revenue

Actual

—

Expected

—

—

—

Consensus estimates

Recent quarters

Q4 2025

-0.26

miss

Q3 2025

-0.27

miss

Q2 2025

-0.28

miss

Q1 2025

-0.13

miss